Related Experiment Videos
The 1987 USA National CAPD Registry report
A S Lindblad1, J W Novak, K D Nolph
1National CAPD Registry Data Coordinating Center, EMMES Corporation, Potomac, Maryland 20854.
ASAIO Transactions
|April 1, 1988
Summary
Continuous Ambulatory Peritoneal Dialysis (CAPD) shows improved patient outcomes, including reduced peritonitis and hospitalization. These positive trends suggest CAPD may become more prominent for end-stage renal disease treatment.
Area of Science:
- Nephrology
- Internal Medicine
- Public Health
Background:
- Continuous Ambulatory Peritoneal Dialysis (CAPD) is a treatment for end-stage renal disease (ESRD).
- Historically, complications like peritonitis have led to high transfer rates from CAPD.
- The National CAPD Registry monitors trends in CAPD therapy in the U.S.
Purpose of the Study:
- To analyze recent trends in CAPD therapy based on data from the National CAPD Registry.
- To assess the impact of improved patient training and management on CAPD outcomes.
- To project the future role of CAPD in ESRD treatment.
Main Methods:
- Analysis of data collected by the National CAPD Registry.
- Tracking patient-reported outcomes, including peritonitis rates and hospitalization days.
- Observational study of trends in complications and transfer rates.
Main Results:
- Patients trained in CAPD report lower peritonitis rates.
- Fewer hospitalization days for dialysis-related events were observed.
- The probability of experiencing a first complication has decreased.
Conclusions:
- Encouraging trends suggest CAPD is an evolving and improving therapy.
- Decreasing complication and transfer rates may increase CAPD's role in ESRD.
- Further advancements could lead to a reduction in CAPD transfer rates.